ESMO 2020 Expert Video report on atezolizumab in upfront treatment of TNBC

ESMO 2020 Expert Video Report on long term ICI outcomes in lung cancerПодробнее

ESMO 2020 Expert Video Report on the combination of immuno and targeted therapies in melanomaПодробнее

Triple negative breast cancer -follow up | Dr. Narendran Explains! shorts 1Подробнее

ESMO 2020 Expert Video Report on precision medicine in prostate cancerПодробнее

ESMO 2020 Expert Video Report on 1st line ICI for gastro oesophageal cancerПодробнее

ESMO 2020 Highlights on neoadjuvant ICI in early TNBC: The IMpassion031 studyПодробнее

IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancerПодробнее

ESMO 2020 Expert Video Report on studying further advanced ovarian cancerПодробнее

#ESMO21 Highlights on combination of pembrolizumab plus chemotherapy in mTNBC: The KEYNOTE-355 studyПодробнее

Expert Video Report on castration sensitive and resistant prostate cancer - 2021 ASCO Annual MeetingПодробнее

Elizabeth Mittendorf, MD, PhD, considers key takeaways from the Impassion-131 presented at ESMO 2020Подробнее

Expert report on tackling resistance to CDK4/6 inhibitors in ER+/HER2-metastatic breast cancerПодробнее

ESMO 2020 Expert Video Report on CDK4 6i in the adjuvant treatment of breast cancerПодробнее

ESMO 2020 Highlights on lenvatinib plus pembrolizumab in advanced solid tumours: LEAP-005Подробнее

ESMO 2020 Highlights on sacituzumab govitecan in metastatic TNBC: The ASCENT studyПодробнее

Ask the Expert: 2022 ESMO CONGRESS WRAP-UPПодробнее